MX335944B - Composiciones que comprenden sulfato de salbutamol. - Google Patents
Composiciones que comprenden sulfato de salbutamol.Info
- Publication number
- MX335944B MX335944B MX2014004279A MX2014004279A MX335944B MX 335944 B MX335944 B MX 335944B MX 2014004279 A MX2014004279 A MX 2014004279A MX 2014004279 A MX2014004279 A MX 2014004279A MX 335944 B MX335944 B MX 335944B
- Authority
- MX
- Mexico
- Prior art keywords
- salbutamol sulphate
- compositions
- component
- pharmaceutical composition
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una composición farmacéutica que es adecuada para suministro desde un recipiente presurizado. La composición está libre de excipientes polares y comprende: (a) un componente propelente que consiste esencialmente de 1,1-difluoroetano (R-152a); (b) un componente tensioactivo que comprende ácido oleico; y (c) un componente de fármaco que consiste de sulfato de salbutamol. La composición farmacéutica se puede suministrar utilizando un inhalador de dosis medida (MDI).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1117619.5A GB201117619D0 (en) | 2011-10-12 | 2011-10-12 | Compositions |
PCT/GB2012/052544 WO2013054137A1 (en) | 2011-10-12 | 2012-10-12 | Compositions comprising salbutamol sulphate |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014004279A MX2014004279A (es) | 2014-05-28 |
MX335944B true MX335944B (es) | 2016-01-04 |
Family
ID=45091931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014004279A MX335944B (es) | 2011-10-12 | 2012-10-12 | Composiciones que comprenden sulfato de salbutamol. |
Country Status (12)
Country | Link |
---|---|
US (2) | US9517216B2 (es) |
EP (1) | EP2766006B1 (es) |
JP (1) | JP5894283B2 (es) |
CN (1) | CN103874489B (es) |
AU (1) | AU2012322455B2 (es) |
BR (1) | BR112014008602B1 (es) |
CA (1) | CA2851026C (es) |
ES (1) | ES2556586T3 (es) |
GB (1) | GB201117619D0 (es) |
MX (1) | MX335944B (es) |
WO (1) | WO2013054137A1 (es) |
ZA (1) | ZA201402321B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201306984D0 (en) * | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
EP3383366B2 (en) * | 2015-12-04 | 2024-06-05 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition |
GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
BR112019005168A2 (pt) * | 2016-09-19 | 2019-06-11 | Mexichem Fluor Sa De Cv | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica |
CA3037080C (en) * | 2016-09-19 | 2021-05-18 | Mexichem Fluor S.A. De C.V. | Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis) |
ES2904823T3 (es) * | 2016-09-19 | 2022-04-06 | Mexichem Fluor Sa De Cv | Composición farmacéutica que comprende bromuro de tiotropio |
ES2841649T5 (es) * | 2016-09-19 | 2024-04-24 | Mexichem Fluor Sa De Cv | Composición farmacéutica |
EP3515432B1 (en) | 2016-09-19 | 2021-08-25 | Mexichem Fluor S.A. de C.V. | Pharmaceutical composition comprising glycopyrrolate |
GB2573297A (en) * | 2018-04-30 | 2019-11-06 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
GB2584686A (en) * | 2019-06-11 | 2020-12-16 | Mexichem Fluor Sa De Cv | Methods |
FR3130554A1 (fr) | 2021-12-20 | 2023-06-23 | Aptar France Sas | Composition pharmaceutique comprenant du salbutamol |
FR3137830A1 (fr) | 2022-07-13 | 2024-01-19 | Aptar France Sas | Composition pharmaceutique comprenant du salbutamol |
WO2024033941A1 (en) * | 2022-08-10 | 2024-02-15 | Cipla Limited | A pharmaceutical composition of salbutamol and pharmaceutical green propellant |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
US5439670A (en) | 1989-11-28 | 1995-08-08 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
IL97065A (en) * | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
DE4003272A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
ATE150296T1 (de) * | 1991-12-18 | 1997-04-15 | Minnesota Mining & Mfg | Aerosolzusammensetzungen für arzneimittelsuspensionen |
US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
CZ288146B6 (en) | 1994-12-22 | 2001-05-16 | Astra Ab | Pharmaceutical aerosol preparation, process of its preparation and use |
PL180895B1 (pl) | 1995-04-14 | 2001-04-30 | Glaxo Wellcome Inc | Inhalator z dozymetrem |
EP1019023B1 (en) | 1997-09-29 | 2003-05-07 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
US6103266A (en) | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6475467B1 (en) | 1998-08-04 | 2002-11-05 | Jago Research Ag | Medicinal aerosol formulations |
GB2392164B (en) | 1999-09-11 | 2004-04-07 | Glaxo Group Ltd | Pharmaceutical formulation of fluticasone propionate |
US6432415B1 (en) | 1999-12-17 | 2002-08-13 | Axrix Laboratories, Inc. | Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces |
CN1144582C (zh) | 2000-11-28 | 2004-04-07 | 中国药科大学 | 治疗呼吸系统疾病的无氟里昂药用气雾剂 |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
GB0323685D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
CN1559389A (zh) * | 2004-03-05 | 2005-01-05 | 山东京卫制药有限公司 | 硫酸左旋沙丁胺醇气雾剂及其制备工艺 |
US20060018840A1 (en) | 2004-06-28 | 2006-01-26 | Nektar Therapeutics | Aerosolizable formulation comprising nicotine |
WO2007020204A2 (en) | 2005-08-12 | 2007-02-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate |
CN101428010A (zh) * | 2008-12-12 | 2009-05-13 | 国家纳米技术与工程研究院 | 一种硫酸沙丁胺醇细粉的制备方法 |
GB0915106D0 (en) | 2009-08-28 | 2009-10-07 | Glaxo Group Ltd | Process |
-
2011
- 2011-10-12 GB GBGB1117619.5A patent/GB201117619D0/en not_active Ceased
-
2012
- 2012-10-12 AU AU2012322455A patent/AU2012322455B2/en active Active
- 2012-10-12 ES ES12787054.1T patent/ES2556586T3/es active Active
- 2012-10-12 BR BR112014008602-8A patent/BR112014008602B1/pt active IP Right Grant
- 2012-10-12 JP JP2014535167A patent/JP5894283B2/ja active Active
- 2012-10-12 WO PCT/GB2012/052544 patent/WO2013054137A1/en active Application Filing
- 2012-10-12 EP EP12787054.1A patent/EP2766006B1/en active Active
- 2012-10-12 US US14/351,075 patent/US9517216B2/en active Active
- 2012-10-12 MX MX2014004279A patent/MX335944B/es unknown
- 2012-10-12 CN CN201280049866.0A patent/CN103874489B/zh active Active
- 2012-10-12 CA CA2851026A patent/CA2851026C/en active Active
-
2014
- 2014-03-28 ZA ZA2014/02321A patent/ZA201402321B/en unknown
-
2016
- 2016-11-21 US US15/357,279 patent/US10039828B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10039828B2 (en) | 2018-08-07 |
BR112014008602A2 (pt) | 2017-04-18 |
US20140230812A1 (en) | 2014-08-21 |
EP2766006B1 (en) | 2015-11-25 |
US9517216B2 (en) | 2016-12-13 |
CN103874489A (zh) | 2014-06-18 |
EP2766006A1 (en) | 2014-08-20 |
US20170165367A1 (en) | 2017-06-15 |
GB201117619D0 (en) | 2011-11-23 |
CA2851026C (en) | 2016-01-05 |
AU2012322455B2 (en) | 2015-07-02 |
ZA201402321B (en) | 2015-03-25 |
JP2014528470A (ja) | 2014-10-27 |
BR112014008602B1 (pt) | 2022-05-24 |
CA2851026A1 (en) | 2013-04-18 |
CN103874489B (zh) | 2016-01-20 |
WO2013054137A1 (en) | 2013-04-18 |
ES2556586T3 (es) | 2016-01-19 |
JP5894283B2 (ja) | 2016-03-23 |
AU2012322455A1 (en) | 2014-04-17 |
MX2014004279A (es) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014004279A (es) | Composiciones que comprenden sulfato de salbutamol. | |
MX2014004364A (es) | Composiciones que comprenden sulfato de salbutamol. | |
MX2015014513A (es) | Composicion que comprende sulfato de salbutamol. | |
MX340924B (es) | Composiciones farmaceuticas. | |
WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
MX355833B (es) | Metodo y formulacion para inhalacion. | |
WO2008053253A3 (en) | Inhaler devices and bespoke pharmaceutical compositions | |
PH12015502593A1 (en) | COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS | |
JP2014528470A5 (es) | ||
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
WO2013104892A8 (en) | Application of high dose compounds via inhalation | |
MY175781A (en) | Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation | |
JP2014530231A5 (es) | ||
IN2014DN01619A (es) | ||
MX2015015132A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
MX2012004338A (es) | Formulaciones mejoradas. | |
AR123674A2 (es) | Composición farmacéutica en aerosol de formoterol y dipropionato de beclometasona | |
MX2023003754A (es) | Formulacion farmaceutica para inhalador presurizado de dosis medidas. | |
MY184654A (en) | Novel dosage form and formulation of abediterol | |
MX2016014604A (es) | Dispositivo de aerosol. | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
GB201118188D0 (en) | Manufacture of medicinal aerosol canisters | |
MY191712A (en) | Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation | |
NZ599901A (en) | Improved medicinal aerosol formulations | |
MX2015015150A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. |